Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
8661 | 1231 | 31.8 | 67% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
284 | 3 | POLYCYSTIC OVARY SYNDROME//ENDOCRINOLOGY & METABOLISM//CORTISOL | 42633 |
1328 | 2 | GLUCOCORTICOID RECEPTOR//ANTIPROGESTIN//JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY | 8395 |
8661 | 1 | ANTIPROGESTIN//MIFEPRISTONE//PROGESTERONE ANTAGONIST | 1231 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ANTIPROGESTIN | authKW | 1350473 | 8% | 55% | 99 |
2 | MIFEPRISTONE | authKW | 888763 | 15% | 20% | 181 |
3 | PROGESTERONE ANTAGONIST | authKW | 429914 | 2% | 67% | 26 |
4 | RU486 | authKW | 428608 | 7% | 20% | 88 |
5 | ONAPRISTONE | authKW | 408183 | 2% | 69% | 24 |
6 | SELECTIVE PROGESTERONE RECEPTOR MODULATORS | authKW | 372585 | 2% | 58% | 26 |
7 | PROGESTERONE RECEPTOR MODULATORS | authKW | 280453 | 2% | 54% | 21 |
8 | ULIPRISTAL ACETATE | authKW | 242605 | 2% | 33% | 30 |
9 | PR ANTAGONISTS | authKW | 223233 | 1% | 100% | 9 |
10 | ASOPRISNIL | authKW | 200077 | 1% | 73% | 11 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Obstetrics & Gynecology | 19926 | 39% | 0% | 474 |
2 | Reproductive Biology | 12947 | 20% | 0% | 249 |
3 | Endocrinology & Metabolism | 3770 | 22% | 0% | 271 |
4 | Chemistry, Medicinal | 585 | 7% | 0% | 88 |
5 | Biochemistry & Molecular Biology | 157 | 14% | 0% | 171 |
6 | Pharmacology & Pharmacy | 129 | 9% | 0% | 106 |
7 | Chemistry, Organic | 96 | 6% | 0% | 70 |
8 | Oncology | 75 | 6% | 0% | 77 |
9 | Demography | 64 | 1% | 0% | 8 |
10 | Medicine, General & Internal | 41 | 4% | 0% | 55 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CONTRACEPT DEV NETWORK | 77261 | 1% | 35% | 9 |
2 | POST GYNAECOL OBSTETR | 74411 | 0% | 100% | 3 |
3 | EQUIPE ACCUEIL 1533 | 49607 | 0% | 100% | 2 |
4 | LASERTECHNOL MED METROL | 49607 | 0% | 100% | 2 |
5 | OBSTET GYNECOL REPROD MED PUBL HLTH | 49607 | 0% | 100% | 2 |
6 | CANC METASTASIS ALERT PREVENT | 32921 | 1% | 15% | 9 |
7 | FERTIL CONTROL HORMONE THER Y | 31887 | 0% | 43% | 3 |
8 | SHANGHAI FAMILY PLANNING TECH RUCT | 30522 | 0% | 31% | 4 |
9 | JONES REPROD MED OBSTET GYNECOL | 27900 | 0% | 38% | 3 |
10 | CONTRACEPT REPROD HLTH BRANCH | 26892 | 1% | 14% | 8 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CONTRACEPTION | 61679 | 9% | 2% | 110 |
2 | HUMAN REPRODUCTION | 22481 | 9% | 1% | 107 |
3 | STEROIDS | 15412 | 4% | 1% | 52 |
4 | JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY | 10521 | 5% | 1% | 62 |
5 | FERTILITY AND STERILITY | 4692 | 4% | 0% | 55 |
6 | BAILLIERES CLINICAL OBSTETRICS AND GYNAECOLOGY | 3393 | 1% | 2% | 9 |
7 | JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 2447 | 4% | 0% | 49 |
8 | ADVANCES IN CONTRACEPTION | 2126 | 0% | 2% | 4 |
9 | FAMILY PLANNING PERSPECTIVES | 1237 | 1% | 1% | 8 |
10 | HOUSTON LAW REVIEW | 1126 | 0% | 5% | 1 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ANTIPROGESTIN | 1350473 | 8% | 55% | 99 | Search ANTIPROGESTIN | Search ANTIPROGESTIN |
2 | MIFEPRISTONE | 888763 | 15% | 20% | 181 | Search MIFEPRISTONE | Search MIFEPRISTONE |
3 | PROGESTERONE ANTAGONIST | 429914 | 2% | 67% | 26 | Search PROGESTERONE+ANTAGONIST | Search PROGESTERONE+ANTAGONIST |
4 | RU486 | 428608 | 7% | 20% | 88 | Search RU486 | Search RU486 |
5 | ONAPRISTONE | 408183 | 2% | 69% | 24 | Search ONAPRISTONE | Search ONAPRISTONE |
6 | SELECTIVE PROGESTERONE RECEPTOR MODULATORS | 372585 | 2% | 58% | 26 | Search SELECTIVE+PROGESTERONE+RECEPTOR+MODULATORS | Search SELECTIVE+PROGESTERONE+RECEPTOR+MODULATORS |
7 | PROGESTERONE RECEPTOR MODULATORS | 280453 | 2% | 54% | 21 | Search PROGESTERONE+RECEPTOR+MODULATORS | Search PROGESTERONE+RECEPTOR+MODULATORS |
8 | ULIPRISTAL ACETATE | 242605 | 2% | 33% | 30 | Search ULIPRISTAL+ACETATE | Search ULIPRISTAL+ACETATE |
9 | PR ANTAGONISTS | 223233 | 1% | 100% | 9 | Search PR+ANTAGONISTS | Search PR+ANTAGONISTS |
10 | ASOPRISNIL | 200077 | 1% | 73% | 11 | Search ASOPRISNIL | Search ASOPRISNIL |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | GOYENECHE, AA , TELLERIA, CM , (2015) ANTIPROGESTINS IN GYNECOLOGICAL DISEASES.REPRODUCTION. VOL. 149. ISSUE 1. P. R15 -R33 | 93 | 47% | 3 |
2 | LI, WL , LI, X , ZHANG, B , GAO, CM , CHEN, YZ , JIANG, YY , (2016) CURRENT PROGRESSES AND TRENDS IN THE DEVELOPMENT OF PROGESTERONE RECEPTOR MODULATORS.CURRENT MEDICINAL CHEMISTRY. VOL. 23. ISSUE 23. P. 2507 -2554 | 67 | 58% | 0 |
3 | SPITZ, IM , BARDIN, CW , (1993) CLINICAL-PHARMACOLOGY OF RU-486 - AN ANTIPROGESTIN AND ANTIGLUCOCORTICOID.CONTRACEPTION. VOL. 48. ISSUE 5. P. 403-444 | 89 | 79% | 55 |
4 | VANLOOK, PFA , BYGDEMAN, M , (1989) ANTIPROGESTATIONAL STEROIDS - A NEW DIMENSION IN HUMAN-FERTILITY REGULATION.OXFORD REVIEWS OF REPRODUCTIVE BIOLOGY. VOL. 11. ISSUE . P. 1-60 | 108 | 79% | 30 |
5 | CHEN, JZ , WANG, JC , SHAO, JW , GAO, Y , XU, JG , YU, SH , LIU, ZH , JIA, L , (2014) THE UNIQUE PHARMACOLOGICAL CHARACTERISTICS OF MIFEPRISTONE (RU486): FROM TERMINATING PREGNANCY TO PREVENTING CANCER METASTASIS.MEDICINAL RESEARCH REVIEWS. VOL. 34. ISSUE 5. P. 979 -1000 | 51 | 65% | 8 |
6 | BOUCHARD, P , CHABBERT-BUFFET, N , FAUSER, BCJM , (2011) SELECTIVE PROGESTERONE RECEPTOR MODULATORS IN REPRODUCTIVE MEDICINE: PHARMACOLOGY, CLINICAL EFFICACY AND SAFETY.FERTILITY AND STERILITY. VOL. 96. ISSUE 5. P. 1175 -1189 | 65 | 51% | 43 |
7 | WILKENS, J , CRITCHLEY, H , (2010) PROGESTERONE RECEPTOR MODULATORS IN GYNAECOLOGICAL PRACTICE.JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE. VOL. 36. ISSUE 2. P. 87-92 | 54 | 72% | 2 |
8 | PURI, CP , VANLOOK, PFA , (1991) NEWLY DEVELOPED COMPETITIVE PROGESTERONE ANTAGONISTS FOR FERTILITY-CONTROL.FRONTIERS OF HORMONE RESEARCH. VOL. 19. ISSUE . P. 127-167 | 88 | 78% | 18 |
9 | SPITZ, IM , BARDIN, CW , (1993) DRUG-THERAPY - MIFEPRISTONE (RU-486) - A MODULATOR OF PROGESTIN AND GLUCOCORTICOID ACTION.NEW ENGLAND JOURNAL OF MEDICINE. VOL. 329. ISSUE 6. P. 404-412 | 65 | 81% | 127 |
10 | CHABBERT-BUFFET, N , MEDURI, G , BOUCHARD, P , SPITZ, IM , (2005) SELECTIVE PROGESTERONE RECEPTOR MODULATORS AND PROGESTERONE ANTAGONISTS: MECHANISMS OF ACTION AND CLINICAL APPLICATIONS.HUMAN REPRODUCTION UPDATE. VOL. 11. ISSUE 3. P. 293 -307 | 68 | 49% | 141 |
Classes with closest relation at Level 1 |